|

T89 capsule Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Tasly Pharmaceuticals, Inc.1

Indications

  • Chronic Stable Angina Pectoris1
  • Heart Disease1

Naples, Florida1 trial

Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

Southwest Florida Research LLC

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.